Skip to content
HealthMinute.TV

HealthMinute.TV

  • Home
  • Derm.City
  • Derm.Business
  • Chronicle Companies
  • Contact

Category: psoriasis

November 11, 2026November 13, 2026 chroniclepublishing psoriasis

Risankizumab effective long-term, extended-interval dosing in PsO patients

According to a recent study, risankizumab showed high complete-clearance rates long-term in adult psoriasis patients with extended-interval dosing in select stable responders.

October 28, 2026October 29, 2026 chroniclepublishing psoriasis

Vitamin B5 derivative may be potential treatment for PsO

According to a recent study, patients taking tablets containing a vitamin B5 derivative known as pantethine experienced improved psoriasis symptoms.

October 7, 2026October 8, 2026 chroniclepublishing psoriasis

Tildrakizumab linked to epigenetic age deviation in PsO patients

According to a recent study, psoriasis patients treated with tildrakizumab saw a reversal of epigenetic aging—changes in gene expression over time that are associated with increased mortality.

August 19, 2026August 20, 2026 chroniclepublishing psoriasis

Zasocitinib effective in treating PsO in hard-to-treat areas

According to a recent press release, zasocitinib, an oral TYK2 inhibitor, is effective in improving skin clearance for psoriasis patients in hard-to-treat areas with once-daily treatment.

July 8, 2026July 10, 2026 chroniclepublishing psoriasis

Exercise, diet, psychological interventions may complement conventional therapy for PsO

According to a recent study, lifestyle changes and nutritional interventions may complement conventional therapy for psoriasis patients.

June 17, 2026June 18, 2026 chroniclepublishing atopic dermatitis, psoriasis

PsO patients trust topicals less than AD patients

According to a recent study, trust levels regarding topical therapy were higher among atopic dermatitis (AD) patients than psoriasis (PsO) patients.

June 10, 2026June 11, 2026 chroniclepublishing psoriasis

Text message intervention effective in improving cardiovascular risk in PsO patients

According to a recent study, a text message intervention system improved cardiovascular risk behaviours and patient confidence managing their health in adult psoriasis patients.

May 20, 2026 chroniclepublishing psoriasis

Concomitant ixekizumab, tirzepatide improves skin clearance, reduces weight in PsO patients

According to a recent study, concomitant ixekizumab and tirzepatide improved skin clearance and reductions in weight in patients with moderate-to-severe psoriasis.

May 13, 2026May 12, 2026 chroniclepublishing psoriasis

Risankizumab linked to lower risk of serious infection than other systemic treatments

According to a recent study, risankizumab was associated with a lower risk of serious infections when compared to other systemic treatments for psoriasis.

February 5, 2026 chroniclepublishing psoriasis

Researchers review relative efficacy of immunomodulatory therapies for scalp PsO

Researchers recently reviewed the relative efficacy of 22 immunomodulatory treatments, including placebo, for the treatment of scalp psoriasis.

Posts navigation

Older posts
Create a website or blog at WordPress.com
HealthMinute.TV
Create a website or blog at WordPress.com
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Subscribe Subscribed
    HealthMinute.TV
    Join 60 other subscribers

    Have a WordPress.com account? Log in now.

  • HealthMinute.TV
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar
Loading Comments...
Create your own website, free on WordPress.com.Create your own website.
Start free